Site updated at Wednesday, 22 June 2016

Living with Dementia


Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   


dementia causes3 - high blood pressure7 - startle myoclonus1 - risk of developing parkinson's1 - dementia sufferers1 - congestive heart failure1 - cognitive abilities1 - neuroscience2 - amyloid beta precursor protein1 - alzheimer's researchers1 - signs of alzheimers1 - dementia symptoms3 - anticholinergics1 - amyloid proteins1 - wernicke-korsakoff syndrome15 - aids related dementia1 - benadryl1 - nerve cell1 - menopause1 - beta amyloid protein1 - long-term dementia1 - physical reality exercises1 - skin problems1 - leeza gibbons1 - alzheimer's drug5 - treat alzheimer's1 - fuller1 - phosphorylated alpha-synuclein1 - diagnosis of dementia1 - alzheimer's patient1 -